Healthcare

Anixa Biosciences continues to advance its oncology pipeline, supported by encouraging clinical data and a shareholder-endorsed management team. Recent developments...

Following a robust performance in fiscal 2025, Legend Biotech Corp is on the cusp of reaching profitability. Company leadership projects...

A significant clinical milestone has been reached in the treatment of generalized anxiety disorder (GAD), a condition affecting over 20...

A significant period of technical support for Ypsomed shares is set to end next Tuesday. The Swiss medical technology specialist...

Biotechnology firm Onco-Innovations has fortified its financial position by completing a private placement, securing crucial capital for its preclinical cancer...

Pharmaceutical giant Eli Lilly issued a significant public safety alert on March 12, 2026, concerning chemically contaminated compounded versions of...

In a strategic pivot that reshapes its market position, telehealth provider Hims & Hers Health has entered a major collaboration...

Animal health company Zoetis is confronting a challenging market phase, characterized by stock price pressure and a cooling companion animal...

The oncology sector is entering a period of intense scrutiny, with 2026 broadly viewed as a watershed year for late-stage...

Axsome Therapeutics has surpassed the $500 million revenue mark in the third year since launching its antidepressant, Auvelity. This commercial...